anonymous
Guest
anonymous
Guest
Record them using your sponge bob secret agent toy video cam.
Record them using your sponge bob secret agent toy video cam.
Crooked company, this pricing thing is going to catch up with us.
Biofrontera has sued DUSA. I don't think there will be another price increase in 2018. This should eliminate a major buying argument for doctors. The ship is sinking... TIC TOC
Biofrontera has sued DUSA. I don't think there will be another price increase in 2018. This should eliminate a major buying argument for doctors. The ship is sinking... TIC TOC
... and Sun has sued Biofrontera. We’re both ‘guilty’, let’s just duke in out in the market. A lot of Sun people went there , along with knowledge and customer lists. And we’ve got a shady distribution system that rewards FC to hold huge inventories and manipulate the ASP, and derms win bc they can buy in and then bill at a higher level. They’re not making anywhere near that % return on their stock portfolios.
my voteWho’ll turn first:
(A) Michael Cohen
(B) Ron Groff
Each day Ron Groff wakes up and must wonder: Is this the day the OIG takes me out in handcuffs?
What a way to live....karma
Can you imagine if Dilip were to be in the US and he gets cuffed at airport check-in ? Not even his 10 billion helps at that point. Ask Madoff.
Did any of you notice that Dillip made a HUGE investment into SC Pharma? He owns 10% of that company and Abdhay is on their board because of the investment. Then SC got a CRL on their device last month. Dillip lost hundreds of millions on this. The guy just cant win in the US market.
You must work for Sun.
I say that because your views are very narrow and distorted, and that’s prerequisite for employment.
First, a ‘HUGE’ investment ? Get real (and get your facts first). For about 13MUSD, Sun got about 13% of the company and a seat on the board (BFD). Now that’s a HUGE investment? Dilip has, idk, something like 15 billion - and throwing 13 million is huge ? And no, he’s not lost ‘hundreds of millions’ on this.
More importantly, it’s symbolic of the complete lack of strategic focus in this company, and it further dilutes focus on ensuring the success of the current US business.
This is small-potatoes, lack of strategy thinking personified.
Just 2 months until levulan patent dies....then compounding will clutter the market and Sun will have zero recourse
There are already compound pharmacies producing ALA - right in my own territory, and most don’t see patent expiration as a real threat.
I’m actually more concerned about our pricing and Biofrontera. They are getting some attention now after pounding the pavement 18 months.